Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Decker

Showing results (51-60 of 180) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry|July 26, 2014
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesteraseFouad H Darras, Beata Kling, Edgar Sawatzky, et al.
ACS Omega|October 6, 2018
Novel <sup>18</sup>F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin SystemXinyu Chen, Mitsuru Hirano, Rudolf A Werner, et al.
International Journal of Occupational Safety and Ergonomics : JOSE|May 19, 2016
The influence of a dynamic elastic garment on musculoskeletal and respiratory wellness in computer usersMichael Decker, Kellie A Gomas, Steven J Narvy, et al.
European Journal of Medicinal Chemistry|May 14, 2014
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamineGuozheng Huang, Beata Kling, Fouad H Darras, et al.
RSC Medicinal Chemistry|September 12, 2022
Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse modelPhilipp Spatz, Thomas Zimmermann, Sophie Steinmüller, et al.
Beilstein Journal of Organic Chemistry|February 2, 2017
Experimental and theoretical investigations into the stability of cyclic aminalsEdgar Sawatzky, Antonios Drakopoulos, Martin Rölz, et al.
Human Cell|May 21, 2017
Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substanceAnika Mann, Thomas Pelz, Knut Rennert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 19, 2025
Affinity-Based Protein Profiling Reveals IDH2 as a Mitochondrial Target of Cannabinol in Receptor-Independent NeuroprotectionEva Schaller, Stephanie Lamer, Andreas Schlosser, et al.
Neuroscience Research|June 18, 2002
Effects of cerebrovascular challenges on plasma endothelinWolfgang Jordan, Michael Decker, Heike Kamrowski, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 27, 2022
Synthesis and Biological Evaluation of Flavonoid-Cinnamic Acid Amide Hybrids with Distinct Activity against Neurodegeneration in Vitro and in VivoJulian Hofmann, Philipp Spatz, Rasmus Walther, et al.
Pageof 18

Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|July 26, 2014
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesteraseFouad H Darras, Beata Kling, Edgar Sawatzky, et al.
ACS Omega|October 6, 2018
Novel <sup>18</sup>F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin SystemXinyu Chen, Mitsuru Hirano, Rudolf A Werner, et al.
International Journal of Occupational Safety and Ergonomics : JOSE|May 19, 2016
The influence of a dynamic elastic garment on musculoskeletal and respiratory wellness in computer usersMichael Decker, Kellie A Gomas, Steven J Narvy, et al.
European Journal of Medicinal Chemistry|May 14, 2014
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamineGuozheng Huang, Beata Kling, Fouad H Darras, et al.
RSC Medicinal Chemistry|September 12, 2022
Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse modelPhilipp Spatz, Thomas Zimmermann, Sophie Steinmüller, et al.
Beilstein Journal of Organic Chemistry|February 2, 2017
Experimental and theoretical investigations into the stability of cyclic aminalsEdgar Sawatzky, Antonios Drakopoulos, Martin Rölz, et al.
Human Cell|May 21, 2017
Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substanceAnika Mann, Thomas Pelz, Knut Rennert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 19, 2025
Affinity-Based Protein Profiling Reveals IDH2 as a Mitochondrial Target of Cannabinol in Receptor-Independent NeuroprotectionEva Schaller, Stephanie Lamer, Andreas Schlosser, et al.
Neuroscience Research|June 18, 2002
Effects of cerebrovascular challenges on plasma endothelinWolfgang Jordan, Michael Decker, Heike Kamrowski, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 27, 2022
Synthesis and Biological Evaluation of Flavonoid-Cinnamic Acid Amide Hybrids with Distinct Activity against Neurodegeneration in Vitro and in VivoJulian Hofmann, Philipp Spatz, Rasmus Walther, et al.
Pageof 18